Pharmacologic prevention of post-ERCP pancreatitis: is nitroglycerin a sangreal?

Gastrointest Endosc. 2006 Sep;64(3):358-60. doi: 10.1016/j.gie.2005.12.027. Epub 2006 May 19.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Catheterization / adverse effects
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Humans
  • Nitroglycerin / therapeutic use*
  • Pancreatitis / prevention & control*
  • Spasm / etiology*
  • Sphincter of Oddi Dysfunction / etiology*
  • Stents
  • Vasodilator Agents / therapeutic use*

Substances

  • Vasodilator Agents
  • Nitroglycerin